Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Cash from Investing Activities (2024 - 2025)

Historic Cash from Investing Activities for Dr Reddys Laboratories (RDY) over the last 3 years, with Q3 2025 value amounting to -$109.4 million.

  • Dr Reddys Laboratories' Cash from Investing Activities rose 5196.18% to -$109.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$804.1 million, marking a year-over-year decrease of 5101.85%. This contributed to the annual value of -$682.0 million for FY2025, which is 4120.08% down from last year.
  • Per Dr Reddys Laboratories' latest filing, its Cash from Investing Activities stood at -$109.4 million for Q3 2025, which was up 5196.18% from -$224.3 million recorded in Q2 2025.
  • In the past 5 years, Dr Reddys Laboratories' Cash from Investing Activities registered a high of -$109.4 million during Q3 2025, and its lowest value of -$242.7 million during Q2 2024.